Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma

Published by Anna Kattainen on Nov 12, 2017

View

Disclaimer

Sponsors

Contact

Abstract

Language

en

PICOS

PICO 10.1

Population
Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
Intervention
LAMA + LABA/ICS
Comparator
LABA/ICS
Outcomes